|
|
|
|
|
|
|
|
|
|
Accelerating Gastrointestinal Recovery - Full Text View - ClinicalTrials.gov
Purpose
This
study is designed to determine whether an oral perioperative medication
(alvimopan--a selective mu antagonist) improves bowel recovery over
placebo after surgery for ovarian cancer.
| Condition | Intervention | Phase |
|---|---|---|
|
Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer |
Drug: Alvimopan Drug: Placebo |
Phase 3 |
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.